TUESDAY, Dec. 6, 2022 (HealthDay News) — The introduction of new melanoma treatments coincided with a reduction in the melanoma mortality rate (MMR) in the United States, according to a study published online Dec. 6 in JAMA Network Open.
Navkirat Kahlon, M.D., M.P.H., from the University of Toledo College of Medicine and Life Sciences in Ohio, and colleagues reviewed changes in the long-term MMR trends in adult patients in the United States using data from the Surveillance, Epidemiology, and End Results database. Outcomes were examined in association with U.S. Food and Drug Administration approval of new drugs for melanoma.
The researchers found that for the first time in the past 40 years, there was a significant reduction in MMR from 2013 to 2017, after the introduction of new treatments in 2011 (most after 2013). From 1975 to 1988, the rates increased (annual percent change, 1.65 percent; 95 percent confidence interval, 1.30 to 2.00 percent; P < 0.001). From 1988 to 2013, there was no significant change in MMR (annual percent change, 0.01 percent; 95 percent confidence interval, −1.10 to 0.12 percent; P = 0.85). From 2013 to 2017, there was a significant decrease in MMR (annual percent change, −6.28 percent; 95 percent confidence interval, −8.52 to −3.97 percent; P < 0.001).
People are also reading…
“The effectiveness of new and innovative therapeutics for melanoma is likely represented by the remarkable and statistically significant drop in population-level melanoma mortality in the last decade,” the authors write. “These are very encouraging data and support the continued development of such therapies.”
One author disclosed financial ties to the pharmaceutical industry.
Stay connected with us on social media platform for instant update click here to join our Twitter, & Facebook
We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.
For all the latest Health News Click Here
For the latest news and updates, follow us on Google News.
Denial of responsibility! NewsAzi is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.
